These studies revealed the potential of claudin-7 as a biomarker for distinguishing chRCC from the remaining three RCC subtypes and indicated the accuracy of microarray technology for detecting diagnostic biomarkers. Here, CLDN7 is linked to chromophobe renal cell carcinoma.